Flight Attendant Medical Research Institute Publications and Presentations: 2003
Publications and Presentations: 2003
Arredondo J, Hall LL, Ndoye A, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Beaudet AL, Grando SA. Central role of fibroblast alpha3 nicotinic acetylcholine receptor in mediating cutaneous effects of nicotine. Lab Invest. 2003;83(2):207-225.
Arredondo J, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Vetter DE, Grando SA. Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. Life Sci. 2003;72(18-19):2063-2067.
Battagli C, Uzzo RG, Dulaimi E, Ibanez de Caceres I, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res. 2003;63(24):8695-8699.
Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis. 2003;46(1):91-111.
Biswal S, Maxwell T, Rangasamy T, Kehrer JP. Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein. Carcinogenesis. 2003;24(8):1401-1406.
Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):11-29.
Burns DM. Tobacco-related diseases. Semin Oncol Nurs. 2003;19(4):244-249.
Carmella SG, Han S, Fristad A, Yang Y, Hecht SS. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomarkers Prev. 2003;12(11 Pt 1):1257-1261.
Foronjy RF, Okada Y, Cole R, D’Armiento J. Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung. Am J Physiol Lung Cell Mol Physiol. 2003;284(5):L727-737.
Halperin AC, Rigotti NA. US public universities’ compliance with recommended tobacco-control policies. J Am Coll Health. 2003;51(5):181-188.
Hastings RH, Araiza F, Burton DW, Zhang L, Bedley M, Deftos LJ. Parathyroid hormone-related protein ameliorates death receptor-mediated apoptosis in lung cancer cells. Am J Physiol Cell Physiol. 2003;285(6):C1429-1436.
Hauguel T, Bunz F. Haploinsufficiency of hTERT leads to telomere dysfunction and radiosensitivity in human cancer cells. Cancer Biol Ther. 2003;2(6):679-684.
Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3(10):733-744.
Hyland A, Puli V, Cummings KM, Sciandra R. New York’s smoke free regulations: Effects on employment and sales in the hospitality industry. . Cornell Hotel and Restaurant Administration Quarterly. 2003;44:9-16.
Kumar SK, Hager E, Pettit C, Gurulingappa H, Davidson NE, Khan SR. Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents. J Med Chem. 2003;46(14):2813-2815.
Lee DJ, Gaynor JJ, Trapido E. Secondhand smoke and earaches in adolescents: the Florida Youth Cohort Study. Nicotine Tob Res. 2003;5(6):943-946.
Lightwood J. The economics of smoking and cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):39-78.
Mai H, May WS, Gao F, Jin Z, Deng X. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem. 2003;278(3):1886-1891.
Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 2003;63(21):7113-7121.
Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism. Int J Cancer. 2003;104(6):758-763.
Minhas KM, Singh B, Jiang WW, Sidransky D, Califano JA. Spindle assembly checkpoint defects and chromosomal instability in head and neck squamous cell carcinoma. Int J Cancer. 2003;107(1):46-52.
Moran S, Thorndike AN, Armstrong K, Rigotti NA. Physicians’ missed opportunities to address tobacco use during prenatal care. Nicotine Tob Res. 2003;5(3):363-368.
Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003;2:41.
Numanami H, Koyama S, Nelson DK, Hoyt JC, Freels JL, Habib MP, Amano J, Haniuda M, Sato E, Robbins RA. Serine protease inhibitors modulate smoke-induced chemokine release from human lung fibroblasts. Am J Respir Cell Mol Biol. 2003;29(5):613-619.
Ott WR, Klepeis NE, Switzer P. Analytical solutions to compartmental indoor air quality models with application to environmental tobacco smoke concentrations measured in a house. J Air Waste Manag Assoc. 2003;53(8):918-936.
Rigotti NA, Regan S, Moran SE, Wechsler H. Students’ opinion of tobacco control policies recommended for US colleges: a national survey. Tob Control. 2003;12(3):251-256.
Salihu HM, Aliyu MH, Pierre-Louis BJ, Alexander GR. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J. 2003;7(4):219-227.
Scollo M, Lal A, Hyland A, Glantz S. Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tob Control. 2003;12(1):13-20.
Shiomi T, Okada Y, Foronjy R, Schiltz J, Jaenish R, Krane S, D’Armiento J. Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1. Exp Lung Res. 2003;29(1):1-15.
Siegel M, Skeer M. Exposure to secondhand smoke and excess lung cancer mortality risk among workers in the “5 B’s”: bars, bowling alleys, billiard halls, betting establishments, and bingo parlours. Tob Control. 2003;12(3):333-338.
Sikder H, Huso DL, Zhang H, Wang B, Ryu B, Hwang ST, Powell JD, Alani RM. Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell. 2003;4(4):291-299.
Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell. 2003;3(6):525-530.
Skeer M, Siegel M. The descriptive epidemiology of local restaurant smoking regulations in Massachusetts: an analysis of the protection of restaurant customers and workers. Tob Control. 2003;12(2):221-226.
Thomson CC, Rigotti NA. Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease. Prog Cardiovasc Dis. 2003;45(6):459-479.
Warner KE, Burns DM. Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob Res. 2003;5(1):37-48.
Watkins DN, Berman DM, Baylin SB. Hedgehog signaling: progenitor phenotype in small-cell lung cancer. Cell Cycle. 2003;2(3):196-198.
Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature. 2003;422(6929):313-317.
Winickoff JP, Glauber JH, Perrin JM, Bock BC, Rigotti NA. Improving tobacco dependence medication use in a Medicaid managed care organization: a practical systems-level approach. J Clin Outcomes Management. 2003;10(10):535-539.
Winickoff JP, Hillis VJ, Palfrey JS, Perrin JM, Rigotti NA. A smoking cessation intervention for parents of children who are hospitalized for respiratory illness: the stop tobacco outreach program. Pediatrics. 2003;111(1):140-145.
Winickoff JP, McMillen RC, Carroll BC, Klein JD, Rigotti NA, Tanski SE, Weitzman M. Addressing parental smoking in pediatrics and family practice: a national survey of parents. Pediatrics. 2003;112(5):1146-1151.
Presentations and Abstracts 2003
Bauer U, Hyland A, Juster H. Evaluating the impact of a statewide smoke-free work place law, NYS, 2003. Presented at the National Conference on Tobacco or Health. Boston, MA, Dec 10-12, 2003.
Blanc PD, Eisner MD, Trupin L, Yelin EH, Katz PP, Balmes JR. Past occupational exposures and respiratory-related work disability predict poorer outcomes in COPD [abstract]. Chest 2003;124:98s-99s.
Bluestein D, Rubenstein D, Jesty J. The effects of mainstream and sidestream cigarette smoke and nicotine on platelet activation under arterial and coronary flow conditions Presented at the World Congress on Medical Physics and Biomedical Engineering. Sidney, Australia, 2003.
Butts MS, Paszkiewicz GM, Timm EA, Hurley EL, Cummings KM, Pauly JL. Fluorescent polycyclic aromatic hydrocarbons (PAH) of tobacco smoke “tar” localized in the cytoplasm of live human lung macrophages from fresh surgically excised lung tissue of lung cancer patients defined by spectral confocal microscopy. Presented at the American Association for Cancer Research, 94th Annual Meeting. Washington, DC, Jul 11-14, 2003.
Eisner MD, Katz PP, Yelin EH, Trupin L, Blanc PD. Measurement of COPD severity: Development and validation of a survey-based instrument [abstract]. Eur Respir J 2003;22:353S.
Hao T, Shi G, Li G, O’Malley BW, Li D. Mutant NBS-1 expression enhances cisplatin-induced cellular DNA damage and cytotoxicity in human head and neck squamous cell carcinoma. Presented at the American Academy of Otolaryngology – Head and Neck Surgery Meeting. Orlando, FL, 2003.
Hsu PYF, Dulbecco FL, Redberg RF, Fleischmann KE, Schiller NB. Doppler pulmonary vascular resistance response during supine exercise in healthy subjects. Presented at the 14th Annual Scientific Sessions of the American Society of Echocardiography. Las Vegas, Nevada, Jun 11-14, 2003.
Hyland A, Higbee C, Bauer J, Giovino G, Wieczorek W, Alford T, Cummings KM. Non-smokers avoid smoky establishments: Findings from Erie/Niagara Counties, NY, 2003. Presented at the National Conference on Tobacco or Health. Boston, MA, Dec 10-12, 2003.
Kim J, Plitt J, Myers A, Schleimer RP. Expression of B7 homolog costimulatory molecules in airway epithelial cells. FASEB Journal 2003;17:C14.
Lee DJ. Round four results of secondhand smoke exposure determined by salivary cotinine and reported earaches in adolescents. Presented at the 12th World Conference on Tobacco or Health. Helsinki, Finland, Aug 3-8, 2003.
Li D, Li G, Shi G, Van Echo DA, Wirtz U, Sreedharan S, O’Malley BW. FGF2-targeted adenovirus-mediated rb94 gene therapy in combination with cisplatin for head and neck squamous cell carcinoma. Presented at the American Association of Cancer Research Meeting. Washington, DC, 2003.
Li D, Li G, Van Echo DA, Wirtz U, Sreedharan S, O’Malley BW. Targeted adenovirus-mediated rb94 and cisplatin approach for head and neck cancer. Presented at the American Academy of Otolaryngology – Head and Neck Surgery Meeting. Orlando, FL, 2003.
Ott WR, Repace JL. Modeling and measuring indoor air pollution from multiple cigarettes smoked in residential settings. Presented at the International Society for Exposure Analysis. Stresa, Italy, 2003.
Ramachandran J, Rubenstein D, Jesty J, Bluestein D. Effects of low-nicotine cigarette smoke on platelet activation under normal coronary flow conditions Presented at the Annual Fall BMES Meeting. Nashville, TN, Oct 1-3, 2003.
Rubenstein D, Jesty J, Bluestein D. The effects of mainstream and secondhand cigarette smoke extracts and nicotine on platelet activation under normal coronary flow conditions. Annual Fall BMES Meeting. Nashville, TN, 2003.
Saha D, Sekhar KR, Cao C, Morrow JD, Choy H, Freeman ML. The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activity. Cancer Res. 2003;63(20):6920-6927.
Shenassa ED, Daskalakis C. Maternal smoking during pregnancy and nicotine dependence among offspring: Implications of research goals, settings, and designs. Presented at the meeting of the Society for Research on Nicotine and Tobacco. New Orleans, LA, Feb 19-22, 2003.
Shi G, Li G, Lang, Yu S, O’Malley BW, Li D. Dominant negative effect of mutant rad50 sensitizes cisplatin-based hemotherapy for human head and neck cancer. Presented at the American Society of Gene Therapy Meeting. Washington, DC, 2003.
Wang XF, Morris C, Qian DZ, Laitala L, Clark DP, Nakanishi O, Pili R. Epigenetic modulation of retinoic acid receptor beta by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma. Proc Amer Assoc Cancer Res 2003;44:794.
Book Chapters, etc., 2003
Burns D, Major J, Anderson C, Vaughn J. Changes in Cross-Sectional Measures of Cessation, Numbers of Cigarettes Smoked per Day, and Time to First Cigarette—California and National Data. In: Burns D, ed. Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? Smoking and Tobacco Control Monographs 2003;15:101-125.
Burns D, Major J, Shanks T. Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses using NHIS. In: Burns D, ed. Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? Smoking and Tobacco Control Monographs 2003;15:83-99.
Burns D, Warner KE. Smokers Who Have Not Quit: Is Cessation More Difficult and Should We Change Our Strategies? In: Burns D, ed. Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? Smoking and Tobacco Control Monographs 2003;15:11-31.
Burns D. The Case Against Hardening of the Target. In: Burns D, ed. Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? Smoking and Tobacco Control Monographs 2003;15:41-48.
Kahn SR. US provisional patent application 60/444,429 “Novel boronic chalcone derivatives and uses thereof”. Filed Feb 3, 2003.
Ladenson PW, Belin RM. Hypothyroidism. In: Bar RS, ed. Early Diagnosis and Treatment of Endocrine Disorders. Totowa, NJ: Human Press, Inc., 2003.
Watkins DN, Berman DM, Baylin SB, Beachy PA. Invention disclosure: “Use of Hedgehog pathway in small cell lung cancer”. 2003.